Israeli cancer diagnosis start-up Imagene AI has raised $21.5 million in first-round financing for its cancer diagnosis platform-based digitised imaging of biopsy samples.
The rapid advancement of immunotherapy in recent years has presented a number of challenges to pharmaceutical firms looking to monitor and measure efficacy in patients.